BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16270046)

  • 1. Differential expression of NF-kappaB pathway genes among peripheral T-cell lymphomas.
    Martínez-Delgado B; Cuadros M; Honrado E; Ruiz de la Parte A; Roncador G; Alves J; Castrillo JM; Rivas C; Benítez J
    Leukemia; 2005 Dec; 19(12):2254-63. PubMed ID: 16270046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation.
    Piccaluga PP; Agostinelli C; Califano A; Carbone A; Fantoni L; Ferrari S; Gazzola A; Gloghini A; Righi S; Rossi M; Tagliafico E; Zinzani PL; Zupo S; Baccarani M; Pileri SA
    Cancer Res; 2007 Nov; 67(22):10703-10. PubMed ID: 18006812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profiling of T-cell lymphomas differentiates peripheral and lymphoblastic lymphomas and defines survival related genes.
    Martinez-Delgado B; Meléndez B; Cuadros M; Alvarez J; Castrillo JM; Ruiz De La Parte A; Mollejo M; Bellas C; Diaz R; Lombardía L; Al-Shahrour F; Domínguez O; Cascon A; Robledo M; Rivas C; Benitez J
    Clin Cancer Res; 2004 Aug; 10(15):4971-82. PubMed ID: 15297397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphoproteomics identifies constitutive activation of the mTORC2/Akt and NF-κB pathways and expressions of IGF-1R, Sirt1, COX-2, and FASN in peripheral T-cell lymphomas: pathogenetic implications and therapeutic options.
    Quesada AE; Nguyen ND; Rios A; Brown RE
    Int J Clin Exp Pathol; 2014; 7(12):8732-9. PubMed ID: 25674239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral T-cell lymphoma gene expression profiles.
    Martinez-Delgado B
    Hematol Oncol; 2006 Sep; 24(3):113-9. PubMed ID: 16676369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus-positive nodal peripheral T cell lymphomas: clinicopathologic and gene expression profiling study.
    Ha SY; Sung J; Ju H; Karube K; Kim SJ; Kim WS; Seto M; Ko YH
    Pathol Res Pract; 2013 Jul; 209(7):448-54. PubMed ID: 23735590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral T-cell lymphoma with follicular T-cell markers.
    Rodríguez-Pinilla SM; Atienza L; Murillo C; Pérez-Rodríguez A; Montes-Moreno S; Roncador G; Pérez-Seoane C; Domínguez P; Camacho FI; Piris MA
    Am J Surg Pathol; 2008 Dec; 32(12):1787-99. PubMed ID: 18779728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
    Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
    J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear factor-kappaB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappaB DNA-binding.
    Van Laere SJ; Van der Auwera I; Van den Eynden GG; Elst HJ; Weyler J; Harris AL; van Dam P; Van Marck EA; Vermeulen PB; Dirix LY
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3249-56. PubMed ID: 16740744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas.
    Ballester B; Ramuz O; Gisselbrecht C; Doucet G; Loï L; Loriod B; Bertucci F; Bouabdallah R; Devilard E; Carbuccia N; Mozziconacci MJ; Birnbaum D; Brousset P; Berger F; Salles G; Briére J; Houlgatte R; Gaulard P; Xerri L
    Oncogene; 2006 Mar; 25(10):1560-70. PubMed ID: 16288225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of NF-kappaB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism.
    Hamoudi RA; Appert A; Ye H; Ruskone-Fourmestraux A; Streubel B; Chott A; Raderer M; Gong L; Wlodarska I; De Wolf-Peeters C; MacLennan KA; de Leval L; Isaacson PG; Du MQ
    Leukemia; 2010 Aug; 24(8):1487-97. PubMed ID: 20520640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NIK controls classical and alternative NF-κB activation and is necessary for the survival of human T-cell lymphoma cells.
    Odqvist L; Sánchez-Beato M; Montes-Moreno S; Martín-Sánchez E; Pajares R; Sánchez-Verde L; Ortiz-Romero PL; Rodriguez J; Rodríguez-Pinilla SM; Iniesta-Martínez F; Solera-Arroyo JC; Ramos-Asensio R; Flores T; Palanca JM; Bragado FG; Franjo PD; Piris MA
    Clin Cancer Res; 2013 May; 19(9):2319-30. PubMed ID: 23536439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus negative clonal plasma cell proliferations and lymphomas in peripheral T-cell lymphomas: a phenomenon with distinctive clinicopathologic features.
    Balagué O; Martínez A; Colomo L; Roselló E; Garcia A; Martínez-Bernal M; Palacín A; Fu K; Weisenburger D; Colomer D; Burke JS; Warnke RA; Campo E
    Am J Surg Pathol; 2007 Sep; 31(9):1310-22. PubMed ID: 17721185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCL10 down-regulation in peripheral T-cell lymphomas.
    Rossi M; Agostinelli C; Righi S; Sabattini E; Bacci F; Gazzola A; Pileri SA; Piccaluga PP
    Hum Pathol; 2012 Dec; 43(12):2266-73. PubMed ID: 22818167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral T-cell lymphomas.
    Savage KJ
    Blood Rev; 2007 Jul; 21(4):201-16. PubMed ID: 17512649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma.
    Loercher A; Lee TL; Ricker JL; Howard A; Geoghegen J; Chen Z; Sunwoo JB; Sitcheran R; Chuang EY; Mitchell JB; Baldwin AS; Van Waes C
    Cancer Res; 2004 Sep; 64(18):6511-23. PubMed ID: 15374962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification of distinct subtypes of peripheral T-cell lymphoma unspecified, identified by chemokine and chemokine receptor expression: Analysis of prognosis.
    Ohshima K; Karube K; Kawano R; Tsuchiya T; Suefuji H; Yamaguchi T; Suzumiya J; Kikuchii M
    Int J Oncol; 2004 Sep; 25(3):605-13. PubMed ID: 15289861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF-kappaB activation through the alternative pathway correlates with chemoresistance and poor survival in extranodal NK/T-cell lymphoma, nasal type.
    Liu X; Wang B; Ma X; Guo Y
    Jpn J Clin Oncol; 2009 Jul; 39(7):418-24. PubMed ID: 19395464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional profiling of the nuclear factor-kappaB pathway identifies a subgroup of primary lymphoma of the central nervous system with low BCL10 expression.
    Courts C; Montesinos-Rongen M; Martin-Subero JI; Brunn A; Siemer D; Zühlke-Jenisch R; Pels H; Jürgens A; Schlegel U; Schmidt-Wolf IG; Schaller C; Reifenberger G; Sabel M; Warnecke-Eberz U; Wiestler OD; Küppers R; Siebert R; Deckert M
    J Neuropathol Exp Neurol; 2007 Mar; 66(3):230-7. PubMed ID: 17356384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
    Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
    Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.